1 study found for:    11044969 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients
Condition: Cytomegalovirus Disease
Interventions: Drug: Certican (everolimus) + valganciclovir;   Drug: Valganciclovir

Indicates status has not been verified in more than two years